Real World Use, Effectiveness and Safety of Romosozumab among Osteoporosis Patients in Guangdong China (20250009)

ENCePP Code of conduct

No

Data sources

• Data source(s), other:
  The data source is the electronic health records in each participating hospital site in GBA Guangdong province. This includes a pre-specified hospital department tracking form designed for Romosozumab. An existing common analytic platform (CAP) of de-identified Romosozumab data will be used for analysis across hospital
• Data sources (types):
  Electronic healthcare records (EHR)

Use of a Common Data Model (CDM)

• CDM mapping:
  No

Data quality specifications

• Check conformance:
  Unknown
• Check completeness:
  Unknown
• Check stability:
  Unknown
• Check logical consistency:
  Unknown

Data characterisation

• Data characterisation conducted:
  Unknown